Skip to main content

Peer Review reports

From: Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)

Original Submission
21 Nov 2017 Submitted Original manuscript
27 Dec 2017 Author responded Author comments - Taro Iguchi
Resubmission - Version 2
27 Dec 2017 Submitted Manuscript version 2
6 Feb 2019 Author responded Author comments - Taro Iguchi
26 Jul 2018 Reviewed Reviewer Report - Rahul Aggarwal
19 Jan 2019 Reviewed Reviewer Report - Laurence Krieger
Resubmission - Version 3
6 Feb 2019 Submitted Manuscript version 3
25 Mar 2019 Author responded Author comments - Taro Iguchi
20 Mar 2019 Reviewed Reviewer Report - Laurence Krieger
Resubmission - Version 4
25 Mar 2019 Submitted Manuscript version 4
Publishing
27 Mar 2019 Editorially accepted
11 Apr 2019 Article published 10.1186/s12885-019-5526-3

You can find further information about peer review here.

Back to article page